HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parrott, C. L. Articles by Santamarina-Fojo, S. Search for Related Content PubMed PubMed Citation Articles by Parrott, C. L. Articles by Santamarina-Fojo, S. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 33, 361-367, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome

CL Parrott, N Alsayed, R Rebourcet and S Santamarina-Fojo
Molecular Disease Branch, National Institutes of Health, Bethesda, MD 20892.

The chemical mismatch method has been utilized to screen for mutations in the apoC-II gene of a patient with familial chylomicronemia and apoC- II deficiency. Cleavage of heteroduplexes formed between normal and patient DNA strands with hydroxylamine and osmium tetroxide readily localized a mutation near base 2660 of the mutant apoC-II. Sequence analysis of PCR amplified patient DNA in the mismatched region localized by this method identified the substitution of a thymidine (T) for a cytosine (C) at base 2668 in exon 2 of the patient's gene within a CpG dinucleotide. The C to T transition in the apoC-IIParis2 gene leads to the introduction of a premature termination codon (TGA) at a position corresponding to amino acid-19 of the signal peptide of apoC- II and the formation of a new Nla III restriction enzyme site absent in the normal apoC-II gene. Consistent with the history of consanguinity in this kindred, amplification of DNA isolated from the proband's parents by the polymerase chain reaction and digestion with Nla III established that the proband is a true homozygote for this genetic defect. Analysis of the patient's plasma by two-dimensional gel electrophoresis and immunoblotting failed to detect any plasma apoC-II. Thus, we have identified a novel mutation in the apoC-II gene of a patient with apoC-II deficiency from a Paris kindred presenting with severe hypertriglyceridemia and chylomicronemia.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Schultz, H. Tu, A. Luk, J. J. Repa, J. C. Medina, L. Li, S. Schwendner, S. Wang, M. Thoolen, D. J. Mangelsdorf, et al. Role of LXRs in control of lipogenesis Genes & Dev., November 15, 2000; 14(22): 2831 - 2838. [Abstract] [Full Text]

				P. V. Bondarenko, S. L. Cockrill, L. K. Watkins, I. D. Cruzado, and R. D. Macfarlane Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein J. Lipid Res., March 1, 1999; 40(3): 543 - 555. [Abstract] [Full Text]

				M. C. Jong, M. H. Hofker, and L. M. Havekes Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3 Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 472 - 484. [Full Text] [PDF]

				A. C. Fitches, R. Appleby, D. A. Lane, V. De Stefano, G. Leone, and R. J. Olds Impaired Cotranslational Processing as a Mechanism for Type I Antithrombin Deficiency Blood, December 15, 1998; 92(12): 4671 - 4676. [Abstract] [Full Text] [PDF]